KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Encompass Health (EHC) EBITDA Margin (2016 - 2025)

Encompass Health (EHC) has disclosed EBITDA Margin for 17 consecutive years, with 17.14% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA Margin fell 3070.0% year-over-year to 17.14%, compared with a TTM value of 1.87% through Dec 2025, down 923.0%, and an annual FY2025 reading of 7.38%, down 372.0% over the prior year.
  • EBITDA Margin was 17.14% for Q4 2025 at Encompass Health, down from 12.12% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 14.18% in Q2 2021 and bottomed at 17.14% in Q4 2025.
  • Average EBITDA Margin over 5 years is 8.22%, with a median of 10.14% recorded in 2021.
  • Peak annual rise in EBITDA Margin hit 1106bps in 2021, while the deepest fall reached -7085bps in 2021.
  • Year by year, EBITDA Margin stood at 11.1% in 2021, then fell by -29bps to 7.86% in 2022, then skyrocketed by 74bps to 13.68% in 2023, then dropped by -1bps to 13.56% in 2024, then tumbled by -226bps to 17.14% in 2025.
  • Business Quant data shows EBITDA Margin for EHC at 17.14% in Q4 2025, 12.12% in Q3 2025, and 3.11% in Q2 2025.